Guardant Health
GH
#3559
Rank
€2.78 B
Marketcap
22,64 €
Share price
-1.18%
Change (1 day)
-11.96%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -4,69 €

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -4,43 €. In 2022 the company made an earnings per share (EPS) of -5,78 € a decrease over its 2021 EPS that were of -3,61 €.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-4,69 €-18.74%
2022-5,78 €60%
2021-3,61 €55.04%
2020-2,33 €207.14%
2019-0,76 €-19.81%
2018-0,95 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-4,35 €-1.83%🇺🇸 USA
-0,11 €-97.57%🇺🇸 USA